Monash IVF faces financial repercussions for embryo mix-ups
The fertility giant, Monash IVF, has agreed to financial settlements with families affected by two significant embryo mix-ups. In 2023, a patient at the Brisbane clinic was implanted with another woman's embryo, resulting in a baby with no genetic connection to the patient. This incident was disclosed in April 2025, prompting an independent investigation and an apology to both the birth and biological mothers.
In June 2025, a second incident occurred at the Clayton clinic in Melbourne. This time, a woman's own embryo was mistakenly transferred, contrary to their treatment plan. Monash IVF promptly apologized and launched an internal investigation, expanding their inquiry to address the initial Brisbane error. The company's spokesperson confirmed settlements with affected families at both clinics, emphasizing their commitment to safety and oversight improvements.
Monash IVF's actions following these incidents include implementing additional verification processes and patient confirmation safeguards. However, the company's CEO, Michael Knaap, resigned days after the second incident was disclosed. An independent review, led by barrister Fiona McLeod, attributed the mix-ups to human error and IT system limitations. The company has since implemented many recommendations from the review and pledged to complete the rest, showcasing their dedication to addressing the issues and ensuring patient safety.
